Bob Martin Clear Plus 402 mg/ 361.8 mg Spot-on Solution for Extra Large Dogs

Nchi: Uingereza

Lugha: Kiingereza

Chanzo: VMD (Veterinary Medicines Directorate)

Viambatanisho vya kazi:

(S)-Methoprene, Fipronil

Inapatikana kutoka:

Bob Martin (UK) Ltd

ATC kanuni:

QP53AX65

INN (Jina la Kimataifa):

(S)-Methoprene, Fipronil

Dawa fomu:

Spot-on solution

Dawa ya aina:

AVM-GSL - Authorised Veterinary Medicine – General Sales List

Kundi la matibabu:

Dogs

Eneo la matibabu:

Ectoparasiticide

Idhini hali ya:

Authorized

Idhini ya tarehe:

2018-08-21

Tabia za bidhaa

Revised: January 2019
AN: 00803/2018
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Bob Martin Clear Plus 402 mg/ 361.8 mg Spot-On Solution for Extra
Large Dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each pipette of 4.02 ml contains:
ACTIVE SUBSTANCES:
Fipronil
402.00 mg
(S)-methoprene
361.80 mg
EXCIPIENTS:
Butylhydroxyanisole (E320)
0.804 mg
Butylhydroxytoluene (E321)
0.402 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Spot-on solution.
Clear amber solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of dogs weighing over 40 kg bodyweight
-
To be used against infestations with fleas, alone or in association
with ticks and/
or biting lice.
-
Treatment of flea infestations (_Ctenocephalides_ spp.). Insecticidal
efficacy
against new infestations with adult fleas persist for 8 weeks.
Prevention of the
multiplication of fleas by inhibiting the development of eggs
(ovicidal activity) and
larvae and pupae (larvicidal activity) originating from eggs laid by
adult fleas for eight
weeks after application.
-
Treatment of tick infestations (_Ixodes_
_ricinus_,
_Dermacentor_
_variabilis,_
_Dermacentor reticulatus_, _Rhipicephalus_ _ sanguineus_) The product
has a persistent
acaricidal efficacy for up to 4 weeks against ticks.
-
Treatment of infestations with biting lice (_Trichodectes canis_).
Page 1 of 7
Revised: January 2019
AN: 00803/2018
4.3
CONTRAINDICATIONS
In the absence of available data, the product should not be used on
puppies less
than 8 weeks old.
Do not use on sick (e.g. systemic diseases, fever) or convalescent
animals.
DO NOT USE IN RABBITS, AS ADVERSE REACTIONS WITH EVEN MORTALITY COULD
OCCUR. In
absence of studies, the use of the product is not recommended in
non-target species.
This product is specifically developed for dogs. Do not use in cats
and ferrets, as this
could lead to overdosing.
Do not use in known cases of hypersensitivity to the active substances
or